Home

ARENA PHARMACEUTICALS INC

CIK 1080709 · last filed 2024-01-29

ARENA PHARMACEUTICALS INC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $96.5M of LBPH on Jan 29, 2024. Across all open-market trades the lifetime net is −$96.5M, making them a net seller over the disclosed history. The firm reports its address in San Diego, CA. 39 SEC filings were submitted jointly with Robert E. Hoffman.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

2

Lifetime Open-Market Net

-$96.48M

Filer Profile

Reported Address
6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
Phone
(858) 453-7200
State of Incorporation
DE
Related Filers
Robert E. Hoffman — 39 joint filings, latest 2014-12-17
Amit Munshi — 25 joint filings, latest 2022-03-11
Tina Susan Nova — 24 joint filings, latest 2022-03-11
BVF PARTNERS L P/IL — 21 joint filings, latest 2004-08-05
BIOTECHNOLOGY VALUE FUND L P — 17 joint filings, latest 2004-07-09
Vincent Aurentz — 16 joint filings, latest 2022-03-11
Christine Anna White — 15 joint filings, latest 2017-06-14
Robert Lisicki — 14 joint filings, latest 2022-03-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Longboard Pharmaceuticals, Inc. (LBPH) Delisted 10%+ Owner 0 $59.98 $0 -$96.48M 2 2024-01-29

Recent Filings

2 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-29 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Sell (S) −3,978,540 -$96.48M EDGAR
2021-03-18 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Conv (C) +138,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.